Items tagged with Access

South Africa: Drug stock outs hit more than one in 10 health facilities (post with simple image)

HIV and tuberculosis (TB) drug stock outs have hit about 14 percent of health facilities nationwide in the last nine months, according to a new study released today by civil society coalition the Stop Stock Outs Project.

MSF launches global campaign urging India to protect access to affordable medicines (post with simple image)

Millions of people in developing countries could be affected if India caves in to pressure.

The need to accelerate access to new drugs for multidrug-resistant tuberculosis (post with simple image)

There needs to be a major scale-up of treatment for MDR tuberculosis that matches the scale-ups that have already been achieved in treatments for HIV and drug-susceptible tuberculosis.

The Medicines Patent Pool releases independent feasibility studies on hepatitis C and tuberculosis (post with simple image)

As part of its ongoing consultation processes on the possibility of the Medicines Patent Pool (MPP) expanding into other disease areas, the organisation has published independent feasibility studies exploring the case for potential entry into hepatitis C and tuberculosis.

TB community reiterates request to Johns Hopkins to review sutezolid licensing agreement with Sequella (post with simple image)

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Joint call regarding health crisis in Donbas, East Ukraine (post with simple image)

Stocks of medicines for drug-resistant tuberculosis are insufficient, and further shortages – leading to more tuberculosis and more drug resistance – are expected.

EECA: Civil Society Consultation to develop the Global Fund’s strategy for 2017-2021 took place (post with simple image)

Suggestions and a strategy guiding relevant advocacy interventions for key priority issues to be considered by the Global Fund’s new Strategy have been developed.

Medicines Patent Pool at 5 years: Promises kept, changes ahead – an interview with Greg Perry (post with simple image)

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

(post with simple image)

ACTION ALERT: Urge Johns Hopkins University to accelerate important TB innovation & keep it accessible for all (post with simple image)

Take Action for TB Today! Sign and share this petition now: https://uaem.wufoo.com/forms/z1dxtbgq0ieib3a/